Validation and performance of a rapid HIV-1 viral load assay
Microbiology Spectrum · 03.11.2026 · 14 (11)
DOI: 10.1128/spectrum.02646-26 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 03.11.2026. Verfasst von Katharine Uhteg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Hospital Medical Microbiology Laboratory, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Viral Load, HIV-1, HIV Infections, Molecular Diagnostic Techniques. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIAID NIH HHS, JG CDC HHS.
Abstract (Originalsprache)
Current diagnostic algorithms for HIV-1 primarily depend on antigen-antibody tests, with nucleic acid tests reserved for confirmation and monitoring of antiretroviral therapy. Incorporating a quantitative nucleic acid test at the point of care could provide faster diagnosis and viral load measurement in a single clinical encounter, expediting linkage to care. This study evaluates the Xpert HIV-1 Viral Load XC (Xpert VL XC) assay as a candidate for primary nucleic acid testing use within HIV-1 diagnostic workflows, compared to standard-of-care approaches. The Xpert VL XC demonstrated a measurable analytical range of 60–1 × 10 6 copies/mL ( R 2 = 0.99) with 100% detection across tested concentrations. Precision analyses showed greatest variability at the lowest concentration, with acceptable assay reproducibility. Agreement analyses using 20 HIV-1 positive and 10 HIV-1 negative plasma samples showed 100% agreement compared to the Roche cobas HIV-1 (quantitative) assay. The Xpert VL XC was compared to four other HIV assays, including the Xpert HIV-1 Qual XC. The Xpert VL XC produced 3.2% invalid results and achieved negative agreement of ≥96.8%. Positive agreement ranged from 80.8% to 90.0%, with most discrepancies occurring below the 40 copies/mL lower limit of quantification threshold. The Xpert HIV-1 Qual XC was the only assay that detected all 26 samples that were positive using the standard immunoassay diagnostic algorithm. Average turnaround time was 3 h, faster than the 21 h average for conventional batch testing. These findings highlight the limitations of implementing rapid molecular HIV-1 diagnostics and the need for both sensitive and rapid approaches. IMPORTANCE Current testing algorithms for the diagnosis of HIV-1 initially test samples with an antigen/antibody test followed by an antibody differentiation test if the screening test is positive. Nucleic acid tests are used to aid in the diagnosis (qualitative and quantitative assays) or monitoring a patient’s response to antiretroviral therapy (quantitative). However, a quantitative diagnostic nucleic acid test may have additional utility, particularly in point-of-care settings, or near the patient care site. This would allow both diagnosis and initial viral load measurement to occur during a single visit, permitting rapid linkage to care. We evaluated the Xpert HIV-1 Viral Load XC test as a potential tool for primary nucleic acid testing within the HIV-1 diagnostic algorithm and assessed its suitability for use under the unique constraints of point-of-care environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johns Hopkins Hospital Medical Microbiology Laboratory, Baltimore, Maryland, USA.
- Division of Infectious Disease, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Division of Medical Microbiology, Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Yukari C Manabe, Matthew M Hamill, Heba H Mostafa
Förderung
- NIBIB NIH HHS
- NIAID NIH HHS
- JG CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Uhteg, K., Bayan, M. H., Boudreau, A., Demko, Z. O., MacGowan, R. J., Delaney, K. P., Manabe, Y. C., Hamill, M. M., & Mostafa, H. H. (2026). Validation and performance of a rapid HIV-1 viral load assay. Microbiology Spectrum, 14(11). https://doi.org/10.1128/spectrum.02646-26
Vancouver
Uhteg K, Bayan MH, Boudreau A, Demko ZO, MacGowan RJ, Delaney KP, et al. Validation and performance of a rapid HIV-1 viral load assay. Microbiology Spectrum. 2026;14(11). doi:10.1128/spectrum.02646-26
BibTeX
@article{Uhteg2026,
author = {Uhteg, Katharine and Bayan, Mohammad H and Boudreau, Alec and Demko, Zoe O and MacGowan, Robin J and Delaney, Kevin P and Manabe, Yukari C and Hamill, Matthew M and Mostafa, Heba H},
title = {Validation and performance of a rapid HIV-1 viral load assay},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {11},
doi = {10.1128/spectrum.02646-26}
}
EUVIMED